Medindia LOGIN REGISTER
Medindia

Amitriptyline Interaction with other Drugs


Amitriptyline is a tricyclic antidepressant, prescribed for depression.

Amitriptyline Interaction with 658 drugs. Find out more in the list below:

3-Iodobenzylguanidine


The therapeutic efficacy of Iobenguane can be decreased when used in combination with Amitriptyline.

4-Hydroxybutyric Acid


The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Amitriptyline.

Abiraterone


The serum concentration of Amitriptyline can be increased when it is combined with Abiraterone.

Advertisement

Acenocoumarol


Amitriptyline may increase the anticoagulant activities of Acenocoumarol.

Acepromazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Acepromazine.

Aceprometazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Aceprometazine.

Advertisement

Acetophenazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Acetophenazine.

Afatinib


The serum concentration of Afatinib can be increased when it is combined with Amitriptyline.

Albuterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.

Advertisement

Alfaxalone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Alfaxalone.

Alfentanil


The risk or severity of adverse effects can be increased when Alfentanil is combined with Amitriptyline.

Almotriptan


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Almotriptan.

Alogliptin


The serum concentration of Amitriptyline can be increased when it is combined with Alogliptin.

alpha 1-Antitrypsin


The serum concentration of Amitriptyline can be increased when it is combined with Alpha-1-proteinase inhibitor.

Alpha 1-Proteinase Inhibitor, Human


The serum concentration of Amitriptyline can be increased when it is combined with Alpha-1-proteinase inhibitor.

Alphaprodine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Alphaprodine.

Alprazolam


The risk or severity of adverse effects can be increased when Alprazolam is combined with Amitriptyline.

Altretamine


Altretamine may increase the orthostatic hypotensive activities of Amitriptyline.

Amiodarone


The metabolism of Amitriptyline can be decreased when combined with Amiodarone.

Amisulpride


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Amisulpride.

Amobarbital


The metabolism of Amitriptyline can be increased when combined with Amobarbital.

Amodiaquine


The serum concentration of Amodiaquine can be increased when it is combined with Amitriptyline.

Amoxapine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Amoxapine.

Amphetamine


Amitriptyline may increase the stimulatory activities of Amphetamine.

Amprenavir


The serum concentration of Amitriptyline can be increased when it is combined with Amprenavir.

Anagrelide


Amitriptyline may increase the QTc-prolonging activities of Anagrelide.

Antithrombin III


The serum concentration of Amitriptyline can be increased when it is combined with Antithrombin III human.

Antithrombin III, Human


The serum concentration of Amitriptyline can be increased when it is combined with Antithrombin III human.

Apalutamide


The serum concentration of Amitriptyline can be decreased when it is combined with Apalutamide.

Apixaban


The serum concentration of Amitriptyline can be increased when it is combined with Apixaban.

Apomorphine


Amitriptyline may decrease the antihypertensive activities of Apomorphine.

Apraclonidine


Amitriptyline may decrease the antihypertensive activities of Apraclonidine.

Aprepitant


The serum concentration of Amitriptyline can be increased when it is combined with Aprepitant.

Aprotinin


The serum concentration of Amitriptyline can be increased when it is combined with Aprotinin.

Arbutamine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Arbutamine.

Arformoterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Arformoterol.

Argatroban


The serum concentration of Amitriptyline can be increased when it is combined with Argatroban.

Argatroban Anhydrous


The serum concentration of Amitriptyline can be increased when it is combined with Argatroban.

Aripiprazole


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Amitriptyline.

Armodafinil


The metabolism of Amitriptyline can be decreased when combined with Armodafinil.

Arsenic Trioxide


Amitriptyline may increase the QTc-prolonging activities of Arsenic trioxide.

Artemether


Amitriptyline may increase the QTc-prolonging activities of Artemether.

Articaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Articaine.

Asenapine


Amitriptyline may increase the QTc-prolonging activities of Asenapine.

Asunaprevir


The serum concentration of Amitriptyline can be increased when it is combined with Asunaprevir.

Atazanavir


The metabolism of Amitriptyline can be decreased when combined with Atazanavir.

Atomoxetine


The metabolism of Amitriptyline can be decreased when combined with Atomoxetine.

Azelastine


Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Azelastine.

Azithromycin


The metabolism of Amitriptyline can be decreased when combined with Azithromycin.

Baclofen


The risk or severity of adverse effects can be increased when Baclofen is combined with Amitriptyline.

Bambuterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Bambuterol.

Barbexaclone


The metabolism of Amitriptyline can be increased when combined with Barbexaclone.

Barbital


The metabolism of Amitriptyline can be increased when combined with Barbital.

Bedaquiline


Amitriptyline may increase the QTc-prolonging activities of Bedaquiline.

Benazepril


The serum concentration of Amitriptyline can be increased when it is combined with Benazepril.

Benoxinate


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Oxybuprocaine.

Benperidol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Benperidol.

Benzocaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Benzocaine.

Benzphetamine


Amitriptyline may decrease the antihypertensive activities of Benzphetamine.

Benzyl Alcohol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Benzyl alcohol.

Betaxolol


The metabolism of Amitriptyline can be decreased when combined with Betaxolol.

Bethanidine


Amitriptyline may decrease the antihypertensive activities of Bethanidine.

Bivalirudin


The serum concentration of Amitriptyline can be increased when it is combined with Bivalirudin.

Boceprevir


The metabolism of Amitriptyline can be decreased when combined with Boceprevir.

Bortezomib


The metabolism of Amitriptyline can be decreased when combined with Bortezomib.

Bosentan


The serum concentration of Amitriptyline can be decreased when it is combined with Bosentan.

Bosutinib


The serum concentration of Bosutinib can be increased when it is combined with Amitriptyline.

Bosutinib monohydrate


The serum concentration of Bosutinib can be increased when it is combined with Amitriptyline.

Brentuximab Vedotin


The serum concentration of Brentuximab vedotin can be increased when it is combined with Amitriptyline.

Brexpiprazole


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Brexpiprazole.

Brimonidine


Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.

Bromazepam


The risk or severity of adverse effects can be increased when Bromazepam is combined with Amitriptyline.

Bromocriptine


Amitriptyline may decrease the antihypertensive activities of Bromocriptine.

Bromperidol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Bromperidol.

Brompheniramine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Brompheniramine.

Brotizolam


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Brotizolam.

Bupivacaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Bupivacaine.

Buprenorphine


Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.

Bupropion


The metabolism of Amitriptyline can be decreased when combined with Bupropion.

Buspirone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Buspirone.

Butabarbital


The risk or severity of adverse effects can be increased when Butabarbital is combined with Amitriptyline.

Butalbital


The risk or severity of adverse effects can be increased when Butalbital is combined with Amitriptyline.

Butamben


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Butamben.

Butobarbital


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Butethal.

Butorphanol


The risk or severity of adverse effects can be increased when Butorphanol is combined with Amitriptyline.

Cabergoline


The risk or severity of adverse effects can be increased when Cabergoline is combined with Amitriptyline.

Caffeine


The metabolism of Amitriptyline can be decreased when combined with Caffeine.

Capecitabine


The metabolism of Amitriptyline can be decreased when combined with Capecitabine.

Captopril


The serum concentration of Amitriptyline can be increased when it is combined with Captopril.

Carbamazepine


The metabolism of Amitriptyline can be increased when combined with Carbamazepine.

Carbinoxamine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Carbinoxamine.

Cariprazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cariprazine.

Carisoprodol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Carisoprodol.

Celecoxib


The metabolism of Amitriptyline can be decreased when combined with Celecoxib.

Celiprolol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Celiprolol.

Ceritinib


The serum concentration of Amitriptyline can be increased when it is combined with Ceritinib.

Cetirizine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cetirizine.

Chloral Hydrate


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chloral hydrate.

Chloramphenicol


The metabolism of Amitriptyline can be decreased when combined with Chloramphenicol.

Chlordiazepoxide


The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Amitriptyline.

Chlormethiazole


The risk or severity of adverse effects can be increased when Amitriptyline is combined with clomethiazole.

Chlormezanone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chlormezanone.

Chloroprocaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chloroprocaine.

Chloroquine


The metabolism of Amitriptyline can be decreased when combined with Chloroquine.

Chlorpheniramine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chlorphenamine.

CHLORPHENIRAMINE POLISTIREX


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chlorphenamine.

Chlorpromazine


The metabolism of Amitriptyline can be decreased when combined with Chlorpromazine.

Chlorprothixene


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chlorprothixene.

Chlorzoxazone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chlorzoxazone.

Cholecalciferol


The metabolism of Amitriptyline can be decreased when combined with Cholecalciferol.

Cholesterol


The serum concentration of Amitriptyline can be increased when it is combined with Cholesterol.

Cilastatin


The serum concentration of Amitriptyline can be increased when it is combined with Cilastatin.

Cilazapril


The serum concentration of Amitriptyline can be increased when it is combined with Cilazapril.

Cilostazol


The serum concentration of Cilostazol can be increased when it is combined with Amitriptyline.

Cimetidine


The metabolism of Amitriptyline can be decreased when combined with Cimetidine.

Cinacalcet


The serum concentration of Amitriptyline can be increased when it is combined with Cinacalcet.

Ciprofloxacin


Amitriptyline may increase the QTc-prolonging activities of Ciprofloxacin.

Cisapride


Amitriptyline may increase the arrhythmogenic activities of Cisapride.

Citalopram


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Citalopram.

Clarithromycin


The metabolism of Amitriptyline can be decreased when combined with Clarithromycin.

Clemastine


The metabolism of Amitriptyline can be decreased when combined with Clemastine.

Clenbuterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Clenbuterol.

Clidinium


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Clidinium.

Clidinium bromide


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Clidinium.

Clobazam


The metabolism of Amitriptyline can be decreased when combined with Clobazam.

Clofezone


The metabolism of Amitriptyline can be decreased when combined with Rabeprazole.

Clomipramine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Clomipramine.

Clonazepam


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Clonazepam.

Clonidine


Amitriptyline may decrease the antihypertensive activities of Clonidine.

Clopidogrel


The metabolism of Amitriptyline can be decreased when combined with Clopidogrel.

Clorazepate


The risk or severity of adverse effects can be increased when Clorazepate is combined with Amitriptyline.

CLORAZEPIC ACID


The risk or severity of adverse effects can be increased when Clorazepate is combined with Amitriptyline.

Clotrimazole


The metabolism of Amitriptyline can be decreased when combined with Clotrimazole.

Clozapine


The metabolism of Amitriptyline can be decreased when combined with Clozapine.

Cobicistat


The serum concentration of Amitriptyline can be increased when it is combined with Cobicistat.

Cocaine


The metabolism of Amitriptyline can be decreased when combined with Cocaine.

Codeine


The risk or severity of adverse effects can be increased when Codeine is combined with Amitriptyline.

Codeine Anhydrous


The risk or severity of adverse effects can be increased when Codeine is combined with Amitriptyline.

CODEINE POLISTIREX


The risk or severity of adverse effects can be increased when Codeine is combined with Amitriptyline.

Colchicine


The serum concentration of Colchicine can be increased when it is combined with Amitriptyline.

Conivaptan


The serum concentration of Conivaptan can be increased when it is combined with Amitriptyline.

Crisaborole


The metabolism of Amitriptyline can be decreased when combined with Crisaborole.

Crizotinib


The metabolism of Amitriptyline can be decreased when combined with Crizotinib.

Cyamemazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cyamemazine.

Cyclizine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cyclizine.

Cyclobenzaprine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cyclobenzaprine.

Cyclosporine


The metabolism of Amitriptyline can be decreased when combined with Cyclosporine.

Cyproheptadine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cyproheptadine.

Cyproterone Acetate


The serum concentration of Amitriptyline can be decreased when it is combined with Cyproterone acetate.

Dabigatran Etexilate


The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Amitriptyline.

Dabrafenib


The serum concentration of Amitriptyline can be decreased when it is combined with Dabrafenib.

Dantrolene


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dantrolene.

Dapiprazole


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dapiprazole.

Darifenacin


The metabolism of Amitriptyline can be decreased when combined with Darifenacin.

Darunavir


The serum concentration of Amitriptyline can be increased when it is combined with Darunavir.

Dasatinib


The serum concentration of Amitriptyline can be increased when it is combined with Dasatinib.

Dasatinib Anhydrous


The serum concentration of Amitriptyline can be increased when it is combined with Dasatinib.

Deferasirox


The serum concentration of Amitriptyline can be decreased when it is combined with Deferasirox.

Delavirdine


The metabolism of Amitriptyline can be decreased when combined with Delavirdine.

Desflurane


The risk or severity of adverse effects can be increased when Desflurane is combined with Amitriptyline.

Desipramine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Desipramine.

Desloratadine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Desloratadine.

Desmopressin


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Desmopressin.

Desvenlafaxine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Desvenlafaxine.

Dexbrompheniramine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dexbrompheniramine.

Dexmedetomidine


Amitriptyline may decrease the antihypertensive activities of Dexmedetomidine.

Dexmethylphenidate


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Amitriptyline.

Dextroamphetamine


Amitriptyline may increase the stimulatory activities of Dextroamphetamine.

Dextromethorphan


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dextromethorphan.

Dextromoramide


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dextromoramide.

Dezocine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dezocine.

Diazepam


The risk or severity of adverse effects can be increased when Diazepam is combined with Amitriptyline.

Dibucaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cinchocaine.

Dicumarol


Amitriptyline may increase the anticoagulant activities of Dicoumarol.

Diethylpropion


Amitriptyline may increase the stimulatory activities of Diethylpropion.

Difenoxin


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Difenoxin.

Dihydrocodeine


The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Amitriptyline.

Dihydroergotamine


Amitriptyline may decrease the antihypertensive activities of Dihydroergotamine.

Diltiazem


The metabolism of Amitriptyline can be decreased when combined with Diltiazem.

Dimenhydrinate


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dimenhydrinate.

Diphenhydramine


The metabolism of Amitriptyline can be decreased when combined with Diphenhydramine.

Diphenoxylate


The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Amitriptyline.

Dipivefrin


Amitriptyline may decrease the antihypertensive activities of Dipivefrin.

Disopyramide


Amitriptyline may increase the QTc-prolonging activities of Disopyramide.

Dobutamine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dobutamine.

Dofetilide


Amitriptyline may increase the QTc-prolonging activities of Dofetilide.

Dolasetron


Amitriptyline may increase the QTc-prolonging activities of Dolasetron.

Domperidone


Amitriptyline may increase the QTc-prolonging activities of Domperidone.

Dothiepin


The metabolism of Amitriptyline can be decreased when combined with Dosulepin.

Doxepin


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Doxepin.

Doxorubicin


The serum concentration of Doxorubicin can be increased when it is combined with Amitriptyline.

Doxorubicin Hydrochloride


The serum concentration of Doxorubicin can be increased when it is combined with Amitriptyline.

Doxycycline


The metabolism of Amitriptyline can be decreased when combined with Doxycycline.

Doxycycline Anhydrous


The metabolism of Amitriptyline can be decreased when combined with Doxycycline.

Doxylamine


Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.

Dronedarone


Amitriptyline may increase the QTc-prolonging activities of Dronedarone.

Droperidol


Droperidol may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.

Droxidopa


Amitriptyline may decrease the antihypertensive activities of Droxidopa.

Duloxetine


Duloxetine may increase the serotonergic activities of Amitriptyline.

Dyclonine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dyclonine.

Edoxaban


The serum concentration of Edoxaban can be increased when it is combined with Amitriptyline.

Efavirenz


The metabolism of Amitriptyline can be decreased when combined with Efavirenz.

Eletriptan


The risk or severity of adverse effects can be increased when Eletriptan is combined with Amitriptyline.

Eliglustat


Amitriptyline may increase the QTc-prolonging activities of Eliglustat.

Enalapril


The serum concentration of Amitriptyline can be increased when it is combined with Enalapril.

Enalaprilat


The serum concentration of Amitriptyline can be increased when it is combined with Enalaprilat.

Enalaprilat Anhydrous


The serum concentration of Amitriptyline can be increased when it is combined with Enalaprilat.

Enflurane


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Enflurane.

Entacapone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Entacapone.

Enzalutamide


The serum concentration of Amitriptyline can be decreased when it is combined with Enzalutamide.

Epigallocatechin Gallate


The serum concentration of Amitriptyline can be increased when it is combined with Epigallocatechin Gallate.

Epinephrine


Amitriptyline may decrease the antihypertensive activities of Epinephrine.

ergoloid mesylates, USP


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ergoloid mesylate.

Ergonovine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ergonovine.

Ergotamine


Amitriptyline may decrease the antihypertensive activities of Ergotamine.

Erythromycin


The metabolism of Amitriptyline can be decreased when combined with Erythromycin.

Escitalopram


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Escitalopram.

Eslicarbazepine Acetate


The metabolism of Amitriptyline can be decreased when combined with Eslicarbazepine acetate.

Esomeprazole


The metabolism of Amitriptyline can be decreased when combined with Esomeprazole.

Estazolam


The risk or severity of adverse effects can be increased when Estazolam is combined with Amitriptyline.

Eszopiclone


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Amitriptyline.

Ethanol


Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Ethanol.

Ethchlorvynol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethchlorvynol.

Ethosuximide


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethosuximide.

Ethotoin


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethotoin.

Ethyl Chloride


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethyl chloride.

Ethyl Loflazepate


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethyl loflazepate.

Ethylmorphine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethylmorphine.

Etidocaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Etidocaine.

Etifoxine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Etifoxine.

Etomidate


Amitriptyline may decrease the antihypertensive activities of Etomidate.

Etravirine


The metabolism of Amitriptyline can be decreased when combined with Etravirine.

Everolimus


The serum concentration of Everolimus can be increased when it is combined with Amitriptyline.

Ezogabine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ezogabine.

Felbamate


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Felbamate.

Felodipine


The metabolism of Amitriptyline can be decreased when combined with Felodipine.

Fenoterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fenoterol.

Fentanyl


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fentanyl.

Fesoterodine


The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Amitriptyline.

Fexofenadine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fexofenadine.

Fibrinolysis Inhibitor


The serum concentration of Amitriptyline can be increased when it is combined with Aprotinin.

Flecainide


Amitriptyline may increase the QTc-prolonging activities of Flecainide.

Flibanserin


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Flibanserin.

Floxuridine


The metabolism of Amitriptyline can be decreased when combined with Floxuridine.

Fluconazole


Amitriptyline may increase the QTc-prolonging activities of Fluconazole.

Fluindione


Amitriptyline may increase the anticoagulant activities of Fluindione.

Flunarizine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Flunarizine.

Flunitrazepam


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Flunitrazepam.

Fluorouracil


The metabolism of Amitriptyline can be decreased when combined with Fluorouracil.

Fluoxetine


The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.

Flupenthixol


Amitriptyline may increase the QTc-prolonging activities of Flupentixol.

Fluphenazine


The risk or severity of adverse effects can be increased when Fluphenazine is combined with Amitriptyline.

Flurazepam


The risk or severity of adverse effects can be increased when Flurazepam is combined with Amitriptyline.

Fluspirilene


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fluspirilene.

Fluticasone propionate


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fluticasone propionate.

Fluvastatin


The metabolism of Amitriptyline can be decreased when combined with Fluvastatin.

Fluvoxamine


The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.

Formoterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Formoterol.

Fosamprenavir


The serum concentration of Amitriptyline can be increased when it is combined with Fosamprenavir.

Fosaprepitant


The serum concentration of Amitriptyline can be increased when it is combined with Fosaprepitant.

Fosinopril


The serum concentration of Amitriptyline can be increased when it is combined with Fosinopril.

Fosphenytoin


The metabolism of Amitriptyline can be increased when combined with Fosphenytoin.

Fospropofol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fospropofol.

Frovatriptan


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Frovatriptan.

Furazolidone


Furazolidone may increase the serotonergic activities of Amitriptyline.

Fusidate


The serum concentration of Amitriptyline can be increased when it is combined with Fusidic Acid.

Fusidic Acid


The serum concentration of Amitriptyline can be increased when it is combined with Fusidic Acid.

Gabapentin


The risk or severity of adverse effects can be increased when Gabapentin is combined with Amitriptyline.

Gabapentin Enacarbil


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Gabapentin Enacarbil.

Gadobenate


Amitriptyline may increase the QTc-prolonging activities of Gadobenic acid.

Gemfibrozil


The metabolism of Amitriptyline can be decreased when combined with Gemfibrozil.

Gemifloxacin


Amitriptyline may increase the QTc-prolonging activities of Gemifloxacin.

Gemifloxacin Mesylate


Amitriptyline may increase the QTc-prolonging activities of Gemifloxacin.

Glutethimide


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Glutethimide.

Goserelin


Amitriptyline may increase the QTc-prolonging activities of Goserelin.

Granisetron


Amitriptyline may increase the QTc-prolonging activities of Granisetron.

Guanabenz


Amitriptyline may decrease the antihypertensive activities of Guanabenz.

Guanfacine


Amitriptyline may decrease the antihypertensive activities of Guanfacine.

Halazepam


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Halazepam.

Haloperidol


The metabolism of Amitriptyline can be decreased when combined with Haloperidol.

Halothane


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Halothane.

Heroin


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Heroin.

Hexobarbital


The metabolism of Amitriptyline can be increased when combined with Hexobarbital.

Hydrocodone


Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.

HYDROCODONE POLISTIREX


Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.

Hydromorphone


The risk or severity of adverse effects can be increased when Hydromorphone is combined with Amitriptyline.

Hydroxyzine


Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.

Hypoxis hemerocallidea root extract


The metabolism of Amitriptyline can be increased when combined with St. John's Wort.

Ibutilide


Amitriptyline may increase the QTc-prolonging activities of Ibutilide.

Idelalisib


The metabolism of Amitriptyline can be decreased when combined with Idelalisib.

Iloperidone


Amitriptyline may increase the QTc-prolonging activities of Iloperidone.

Imatinib


The metabolism of Amitriptyline can be decreased when combined with Imatinib.

Imidapril


The serum concentration of Amitriptyline can be increased when it is combined with Imidapril.

Imipramine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Imipramine.

Indacaterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Indacaterol.

Indinavir


The metabolism of Amitriptyline can be decreased when combined with Indinavir.

INDINAVIR ANHYDROUS


The metabolism of Amitriptyline can be decreased when combined with Indinavir.

Iproniazid


Iproniazid may increase the serotonergic activities of Amitriptyline.

Irbesartan


The metabolism of Amitriptyline can be decreased when combined with Irbesartan.

Isavuconazole


The serum concentration of Amitriptyline can be increased when it is combined with Isavuconazole.

Isavuconazonium


The metabolism of Amitriptyline can be decreased when combined with Isavuconazonium.

Isocarboxazid


The therapeutic efficacy of Amitriptyline can be increased when used in combination with Isocarboxazid.

Isoetharine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Isoetarine.

Isoflurane


The risk or severity of adverse effects can be increased when Isoflurane is combined with Amitriptyline.

Isoflurophate


The serum concentration of Amitriptyline can be increased when it is combined with Isoflurophate.

Isoniazid


The metabolism of Amitriptyline can be decreased when combined with Isoniazid.

Isoproterenol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Isoprenaline.

Isradipine


The metabolism of Amitriptyline can be decreased when combined with Isradipine.

Itraconazole


The metabolism of Amitriptyline can be decreased when combined with Itraconazole.

Ivacaftor


The serum concentration of Amitriptyline can be increased when it is combined with Ivacaftor.

Ixazomib


The serum concentration of Amitriptyline can be increased when it is combined with Ixazomib.

Ketamine


The risk or severity of adverse effects can be increased when Ketamine is combined with Amitriptyline.

Ketazolam


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ketazolam.

Ketoconazole


The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.

Lamotrigine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Lamotrigine.

Lapatinib


The metabolism of Amitriptyline can be decreased when combined with Lapatinib.

Ledipasvir


The serum concentration of Ledipasvir can be increased when it is combined with Amitriptyline.

Leflunomide


The metabolism of Amitriptyline can be decreased when combined with Leflunomide.

Lenvatinib


Amitriptyline may increase the QTc-prolonging activities of Lenvatinib.

Lenvatinib Mesylate


Amitriptyline may increase the QTc-prolonging activities of Lenvatinib.

Lepirudin


The serum concentration of Amitriptyline can be increased when it is combined with Lepirudin.

Leuprolide


Amitriptyline may increase the QTc-prolonging activities of Leuprolide.

Levalbuterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levosalbutamol.

Levetiracetam


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levetiracetam.

Levobupivacaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levobupivacaine.

Levocabastine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levocabastine.

Levocetirizine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levocetirizine.

Levodopa


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levodopa.

Levofloxacin


Amitriptyline may increase the QTc-prolonging activities of Levofloxacin.

Levofloxacin Anhydrous


Amitriptyline may increase the QTc-prolonging activities of Levofloxacin.

Levomethadyl


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levomethadyl Acetate.

Levomilnacipran


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levomilnacipran.

Levonordefrin


Amitriptyline may decrease the antihypertensive activities of Levonordefrin.

Levorphanol


The risk or severity of adverse effects can be increased when Levorphanol is combined with Amitriptyline.

Levothyroxine


Levothyroxine may increase the arrhythmogenic activities of Amitriptyline.

Lidocaine


The metabolism of Amitriptyline can be decreased when combined with Lidocaine.

Linagliptin


The serum concentration of Amitriptyline can be increased when it is combined with Linagliptin.

Linezolid


Linezolid may increase the serotonergic activities of Amitriptyline.

Liothyronine


Liothyronine may increase the arrhythmogenic activities of Amitriptyline.

Lisdexamfetamine


Amitriptyline may increase the stimulatory activities of Lisdexamfetamine.

Lisdexamfetamine Dimesylate


Amitriptyline may increase the stimulatory activities of Lisdexamfetamine.

Lisinopril


The serum concentration of Amitriptyline can be increased when it is combined with Lisinopril.

Lisinopril Anhydrous


The serum concentration of Amitriptyline can be increased when it is combined with Lisinopril.

Lithium


Lithium may increase the neurotoxic activities of Amitriptyline.

Lithium Cation


Lithium may increase the neurotoxic activities of Amitriptyline.

Lofexidine


Amitriptyline may decrease the antihypertensive activities of Lofexidine.

Lopinavir


The metabolism of Amitriptyline can be decreased when combined with Lopinavir.

Loratadine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Loratadine.

Lorazepam


The risk or severity of adverse effects can be increased when Lorazepam is combined with Amitriptyline.

Lorcaserin


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Lorcaserin.

Lormetazepam


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Lormetazepam.

Losartan


The metabolism of Amitriptyline can be decreased when combined with Losartan.

Lovastatin


The metabolism of Amitriptyline can be decreased when combined with Lovastatin.

Loxapine


The risk or severity of adverse effects can be increased when Loxapine is combined with Amitriptyline.

Luliconazole


The serum concentration of Amitriptyline can be increased when it is combined with Luliconazole.

Lumacaftor


The serum concentration of Amitriptyline can be increased when it is combined with Lumacaftor.

Lumefantrine


Amitriptyline may increase the QTc-prolonging activities of Lumefantrine.

Lurasidone


The risk or severity of adverse effects can be increased when Lurasidone is combined with Amitriptyline.

Magnesium Sulfate


The therapeutic efficacy of Amitriptyline can be increased when used in combination with Magnesium sulfate.

MAGNESIUM SULFATE ANHYDROUS


The therapeutic efficacy of Amitriptyline can be increased when used in combination with Magnesium sulfate.

Manidipine


The metabolism of Amitriptyline can be decreased when combined with Manidipine.

Maprotiline


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Maprotiline.

Meclizine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Meclizine.

Melatonin


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Melatonin.

Meperidine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pethidine.

Mephentermine


Amitriptyline may increase the vasopressor activities of Mephentermine.

Mephobarbital


The metabolism of Amitriptyline can be increased when combined with Methylphenobarbital.

Mepivacaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Mepivacaine.

Meprobamate


The risk or severity of adverse effects can be increased when Meprobamate is combined with Amitriptyline.

Mesoridazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Mesoridazine.

Metaproterenol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Orciprenaline.

Metaraminol


Amitriptyline may increase the vasopressor activities of Metaraminol.

Metaxalone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Metaxalone.

Methadone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methadone.

Methadyl Acetate


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methadyl Acetate.

Methamphetamine


Amitriptyline may decrease the antihypertensive activities of Methamphetamine.

Methapyrilene


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methapyrilene.

Methaqualone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methaqualone.

Methocarbamol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methocarbamol.

Methohexital


The metabolism of Amitriptyline can be increased when combined with Methohexital.

Methotrimeprazine


Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.

Methoxamine


Amitriptyline may increase the vasopressor activities of Methoxamine.

Methoxyflurane


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methoxyflurane.

Methsuximide


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methsuximide.

Methylene blue


Amitriptyline may increase the serotonergic activities of Methylene blue.

Methylphenidate


The risk or severity of adverse effects can be increased when Methylphenidate is combined with Amitriptyline.

Metoclopramide


The risk or severity of adverse effects can be increased when Metoclopramide is combined with Amitriptyline.

Metoprolol


The serum concentration of Metoprolol can be increased when it is combined with Amitriptyline.

Metylperon


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Melperone.

Metyrosine


The risk or severity of adverse effects can be increased when Metyrosine is combined with Amitriptyline.

Mexiletine


The metabolism of Amitriptyline can be decreased when combined with Mexiletine.

Midazolam


The risk or severity of adverse effects can be increased when Midazolam is combined with Amitriptyline.

Midodrine


Amitriptyline may increase the vasopressor activities of Midodrine.

Midostaurin


The metabolism of Amitriptyline can be decreased when combined with Midostaurin.

Mifepristone


The serum concentration of Amitriptyline can be increased when it is combined with Mifepristone.

Milnacipran


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Milnacipran.

Minaprine


Minaprine may increase the serotonergic activities of Amitriptyline.

Minocycline


Minocycline may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.

Mirabegron


The metabolism of Amitriptyline can be decreased when combined with Mirabegron.

Mirtazapine


Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.

Mitotane


The serum concentration of Amitriptyline can be decreased when it is combined with Mitotane.

Moclobemide


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Moclobemide.

Modafinil


The metabolism of Amitriptyline can be decreased when combined with Modafinil.

Moexipril


The serum concentration of Amitriptyline can be increased when it is combined with Moexipril.

Molindone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Molindone.

Morphine


The risk or severity of adverse effects can be increased when Morphine is combined with Amitriptyline.

Moxifloxacin


Amitriptyline may increase the QTc-prolonging activities of Moxifloxacin.

Moxonidine


The therapeutic efficacy of Moxonidine can be decreased when used in combination with Amitriptyline.

Nabilone


Nabilone may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.

Nalbuphine


The risk or severity of adverse effects can be increased when Nalbuphine is combined with Amitriptyline.

Naloxegol


The serum concentration of Naloxegol can be increased when it is combined with Amitriptyline.

Naphazoline


Amitriptyline may decrease the antihypertensive activities of Naphazoline.

Naratriptan


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Naratriptan.

Nefazodone


The metabolism of Amitriptyline can be decreased when combined with Nefazodone.

Nelfinavir


The metabolism of Amitriptyline can be decreased when combined with Nelfinavir.

Netupitant


The serum concentration of Amitriptyline can be increased when it is combined with Netupitant.

Nevirapine


The metabolism of Amitriptyline can be increased when combined with Nevirapine.

Nialamide


Nialamide may increase the serotonergic activities of Amitriptyline.

Nicardipine


The metabolism of Amitriptyline can be decreased when combined with Nicardipine.

Nicorandil


Amitriptyline may increase the hypotensive activities of Nicorandil.

Nicotine


The metabolism of Amitriptyline can be decreased when combined with Nicotine.

Nicotine Polacrilex


The metabolism of Amitriptyline can be decreased when combined with Nicotine.

Nilotinib


Amitriptyline may increase the QTc-prolonging activities of Nilotinib.

Nitrazepam


The risk or severity of adverse effects can be increased when Nitrazepam is combined with Amitriptyline.

Nitrous Oxide


The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Amitriptyline.

Norepinephrine


Amitriptyline may decrease the antihypertensive activities of Norepinephrine.

Norflurane


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Norflurane.

Normethadone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Normethadone.

Nortriptyline


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Nortriptyline.

O-PHENANTHROLINE


The serum concentration of Amitriptyline can be increased when it is combined with 1,10-Phenanthroline.

Ofloxacin


Amitriptyline may increase the QTc-prolonging activities of Ofloxacin.

Olanzapine


The risk or severity of adverse effects can be increased when Olanzapine is combined with Amitriptyline.

Olaparib


The metabolism of Amitriptyline can be decreased when combined with Olaparib.

Olodaterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Olodaterol.

Olopatadine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Olopatadine.

Omeprazole


The metabolism of Amitriptyline can be decreased when combined with Omeprazole.

Ondansetron


Amitriptyline may increase the QTc-prolonging activities of Ondansetron.

Opium


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Opium.

Orphenadrine


Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.

Osimertinib


The serum concentration of Amitriptyline can be increased when it is combined with Osimertinib.

Oxazepam


The risk or severity of adverse effects can be increased when Oxazepam is combined with Amitriptyline.

Oxprenolol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Oxprenolol.

Oxycodone


The risk or severity of adverse effects can be increased when Oxycodone is combined with Amitriptyline.

Oxymetazoline


Amitriptyline may decrease the antihypertensive activities of Oxymetazoline.

Oxymorphone


The risk or severity of adverse effects can be increased when Oxymorphone is combined with Amitriptyline.

p-Hydroxyamphetamine


Amitriptyline may increase the stimulatory activities of Hydroxyamphetamine.

Palbociclib


The serum concentration of Amitriptyline can be increased when it is combined with Palbociclib.

Paliperidone


Amitriptyline may decrease the antihypertensive activities of Paliperidone.

Palonosetron


Palonosetron may increase the serotonergic activities of Amitriptyline.

Panobinostat


The serum concentration of Amitriptyline can be increased when it is combined with Panobinostat.

Pantoprazole


The metabolism of Amitriptyline can be decreased when combined with Pantoprazole.

Paraldehyde


Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.

Paregoric


The risk or severity of adverse effects can be increased when Morphine is combined with Amitriptyline.

Pargyline


Pargyline may increase the serotonergic activities of Amitriptyline.

Paroxetine


The risk or severity of adverse effects can be increased when Paroxetine is combined with Amitriptyline.

Pazopanib


The serum concentration of Pazopanib can be increased when it is combined with Amitriptyline.

Peginterferon Alfa-2b


The serum concentration of Amitriptyline can be decreased when it is combined with Peginterferon alfa-2b.

Pentamidine


Amitriptyline may increase the QTc-prolonging activities of Pentamidine.

Pentazocine


The risk or severity of adverse effects can be increased when Pentazocine is combined with Amitriptyline.

Pentobarbital


The metabolism of Amitriptyline can be increased when combined with Pentobarbital.

Perampanel


Perampanel may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.

Perazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Perazine.

Perflutren


Amitriptyline may increase the QTc-prolonging activities of Perflutren.

Pergolide


Amitriptyline may decrease the antihypertensive activities of Pergolide.

Periciazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Propericiazine.

Perindopril


The serum concentration of Amitriptyline can be increased when it is combined with Perindopril.

Perphenazine


The risk or severity of adverse effects can be increased when Perphenazine is combined with Amitriptyline.

Phenelzine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Phenelzine.

Phenindione


Amitriptyline may increase the anticoagulant activities of Phenindione.

Phenobarbital


The metabolism of Amitriptyline can be increased when combined with Phenobarbital.

Phenoxyethanol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Phenoxyethanol.

Phenprocoumon


Amitriptyline may increase the anticoagulant activities of Phenprocoumon.

Phentermine


Amitriptyline may increase the stimulatory activities of Phentermine.

PHENTERMINE RESIN


Amitriptyline may increase the stimulatory activities of Phentermine.

Phenylephrine


Amitriptyline may increase the vasopressor activities of Phenylephrine.

Phenylpropanolamine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Phenylpropanolamine.

Phenytoin


The metabolism of Amitriptyline can be increased when combined with Phenytoin.

Pimozide


Amitriptyline may increase the QTc-prolonging activities of Pimozide.

Pioglitazone


The metabolism of Amitriptyline can be decreased when combined with Pioglitazone.

Pipamperone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pipamperone.

Pipothiazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pipotiazine.

Pirbuterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pirbuterol.

Pirinitramide


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Piritramide.

Pizotyline


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pizotifen.

Pomalidomide


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pomalidomide.

Posaconazole


The metabolism of Amitriptyline can be decreased when combined with Posaconazole.

Pramipexole


Amitriptyline may increase the sedative activities of Pramipexole.

Pramoxine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pramocaine.

Prazepam


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Prazepam.

Pregabalin


The therapeutic efficacy of Amitriptyline can be increased when used in combination with Pregabalin.

Prilocaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Prilocaine.

Primaquine


Amitriptyline may increase the QTc-prolonging activities of Primaquine.

Primidone


The metabolism of Amitriptyline can be increased when combined with Primidone.

Procainamide


Amitriptyline may increase the QTc-prolonging activities of Procainamide.

Procaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Procaine.

Procarbazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Procarbazine.

Procaterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Procaterol.

Prochlorperazine


The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Amitriptyline.

Promazine


The metabolism of Amitriptyline can be decreased when combined with Promazine.

Promethazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Promethazine.

Propafenone


Amitriptyline may increase the QTc-prolonging activities of Propafenone.

Proparacaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Proparacaine.

Propofol


The risk or severity of adverse effects can be increased when Propofol is combined with Amitriptyline.

Propoxyphene


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dextropropoxyphene.

Prothipendyl


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Prothipendyl.

Protriptyline


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Protriptyline.

Pseudoephedrine


Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.

Pyrimethamine


The metabolism of Amitriptyline can be decreased when combined with Pyrimethamine.

Quazepam


The serum concentration of Amitriptyline can be increased when it is combined with Quazepam.

Quetiapine


Amitriptyline may increase the QTc-prolonging activities of Quetiapine.

Quetiapine fumarate


Amitriptyline may increase the QTc-prolonging activities of Quetiapine.

Quinapril


The serum concentration of Amitriptyline can be increased when it is combined with Quinapril.

Quinidine


Amitriptyline may increase the QTc-prolonging activities of Quinidine.

Quinine


Amitriptyline may increase the QTc-prolonging activities of Quinine.

Rabeprazole


The metabolism of Amitriptyline can be decreased when combined with Rabeprazole.

Racecadotril


The serum concentration of Amitriptyline can be increased when it is combined with Racecadotril.

Ramelteon


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ramelteon.

Ramipril


The serum concentration of Amitriptyline can be increased when it is combined with Ramipril.

Ranolazine


The serum concentration of Ranolazine can be increased when it is combined with Amitriptyline.

Rasagiline


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Rasagiline.

Remifentanil


The risk or severity of adverse effects can be increased when Remifentanil is combined with Amitriptyline.

Remoxipride


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Remoxipride.

Reserpine


The risk or severity of adverse effects can be increased when Reserpine is combined with Amitriptyline.

Rifabutin


The metabolism of Amitriptyline can be increased when combined with Rifabutin.

Rifampin


The metabolism of Amitriptyline can be increased when combined with Rifampicin.

Rifapentine


The metabolism of Amitriptyline can be increased when combined with Rifapentine.

Rifaximin


The serum concentration of Rifaximin can be increased when it is combined with Amitriptyline.

Risperidone


Amitriptyline may decrease the antihypertensive activities of Risperidone.

Ritodrine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ritodrine.

Ritonavir


The metabolism of Amitriptyline can be decreased when combined with Ritonavir.

Rivaroxaban


The serum concentration of Amitriptyline can be increased when it is combined with Rivaroxaban.

Rizatriptan


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Rizatriptan.

Rolapitant


The metabolism of Amitriptyline can be decreased when combined with Rolapitant.

Ropinirole


Amitriptyline may increase the sedative activities of Ropinirole.

Ropivacaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ropivacaine.

Rosiglitazone


The metabolism of Amitriptyline can be decreased when combined with Rosiglitazone.

Rotigotine


Amitriptyline may increase the sedative activities of Rotigotine.

Rucaparib


The metabolism of Amitriptyline can be decreased when combined with Rucaparib.

Rufinamide


The risk or severity of adverse effects can be increased when Rufinamide is combined with Amitriptyline.

Salmeterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salmeterol.

Saquinavir


The metabolism of Amitriptyline can be decreased when combined with Saquinavir.

Saquinavir Mesylate


The metabolism of Amitriptyline can be decreased when combined with Saquinavir.

Sarilumab


The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Sarilumab.

Saxagliptin


The serum concentration of Amitriptyline can be increased when it is combined with Saxagliptin.

Saxagliptin Anhydrous


The serum concentration of Amitriptyline can be increased when it is combined with Saxagliptin.

Scopolamine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Scopolamine.

Scopolamine Hydrobromide


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Scopolamine.

Secobarbital


The metabolism of Amitriptyline can be increased when combined with Secobarbital.

Selegiline


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Selegiline.

Sertindole


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sertindole.

Sertraline


The risk or severity of adverse effects can be increased when Sertraline is combined with Amitriptyline.

Sevoflurane


The risk or severity of adverse effects can be increased when Sevoflurane is combined with Amitriptyline.

Sildenafil


The metabolism of Amitriptyline can be decreased when combined with Sildenafil.

Silodosin


The serum concentration of Silodosin can be increased when it is combined with Amitriptyline.

Siltuximab


The serum concentration of Amitriptyline can be decreased when it is combined with Siltuximab.

Simeprevir


The serum concentration of Amitriptyline can be increased when it is combined with Simeprevir.

Sitagliptin


The serum concentration of Amitriptyline can be increased when it is combined with Sitagliptin.

Sitagliptin Phosphate


The serum concentration of Amitriptyline can be increased when it is combined with Sitagliptin.

Sodium Oxybate


Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.

Sodium Phosphate


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sodium phosphate.

Sodium Phosphate, Monobasic


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sodium phosphate.

SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sodium phosphate.

Sorafenib


The metabolism of Amitriptyline can be decreased when combined with Sorafenib.

Sotalol


Amitriptyline may increase the QTc-prolonging activities of Sotalol.

Spirapril


The serum concentration of Amitriptyline can be increased when it is combined with Spirapril.

ST. JOHN'S WORT EXTRACT


The metabolism of Amitriptyline can be increased when combined with St. John's Wort.

Sufentanil


The risk or severity of adverse effects can be increased when Sufentanil is combined with Amitriptyline.

Sulfadiazine


The metabolism of Amitriptyline can be decreased when combined with Sulfadiazine.

Sulfamethoxazole


The metabolism of Amitriptyline can be decreased when combined with Sulfamethoxazole.

Sulfisoxazole


The metabolism of Amitriptyline can be decreased when combined with Sulfisoxazole.

Sulpiride


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sulpiride.

Sumatriptan


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sumatriptan.

Sumatriptan Succinate


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sumatriptan.

Suvorexant


Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.

Tamoxifen


The metabolism of Amitriptyline can be decreased when combined with Tamoxifen.

Tapentadol


Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.

Tasimelteon


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tasimelteon.

Tedizolid


Tedizolid Phosphate may increase the serotonergic activities of Amitriptyline.

Tedizolid Phosphate


Tedizolid Phosphate may increase the serotonergic activities of Amitriptyline.

Telaprevir


The metabolism of Amitriptyline can be decreased when combined with Telaprevir.

Telavancin


Amitriptyline may increase the QTc-prolonging activities of Telavancin.

Telithromycin


The metabolism of Amitriptyline can be decreased when combined with Telithromycin.

Temazepam


The risk or severity of adverse effects can be increased when Temazepam is combined with Amitriptyline.

Tenofovir Disoproxil


The metabolism of Amitriptyline can be decreased when combined with Tenofovir disoproxil.

Terbinafine


The metabolism of Amitriptyline can be decreased when combined with Terbinafine.

Terbutaline


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.

Terbutaline Sulfate


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.

Teriflunomide


The serum concentration of Amitriptyline can be decreased when it is combined with Teriflunomide.

Tetrabenazine


Amitriptyline may increase the QTc-prolonging activities of Tetrabenazine.

Tetracaine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tetracaine.

Tetracaine hydrochloride


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tetracaine.

Tetrahydrocannabinol


Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.

Thalidomide


Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.

Theophylline


The metabolism of Amitriptyline can be decreased when combined with Theophylline.

Theophylline anhydrous


The metabolism of Amitriptyline can be decreased when combined with Theophylline.

Thiamylal


The metabolism of Amitriptyline can be increased when combined with Thiamylal.

Thiopental


The metabolism of Amitriptyline can be increased when combined with Thiopental.

Thiopental Sodium


The metabolism of Amitriptyline can be increased when combined with Thiopental.

Thioproperazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Thioproperazine.

Thioridazine


The serum concentration of Thioridazine can be increased when it is combined with Amitriptyline.

Thiotepa


The metabolism of Amitriptyline can be decreased when combined with Thiotepa.

Thiothixene


The risk or severity of adverse effects can be increased when Thiothixene is combined with Amitriptyline.

Thyroid, Porcine


Thyroid, porcine may increase the arrhythmogenic activities of Amitriptyline.

Tiagabine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tiagabine.

Tiapride


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tiapride.

Ticagrelor


The metabolism of Amitriptyline can be decreased when combined with Ticagrelor.

Ticlopidine


The metabolism of Amitriptyline can be decreased when combined with Ticlopidine.

Tipranavir


The metabolism of Amitriptyline can be decreased when combined with Tipranavir.

Tizanidine


The serum concentration of Tizanidine can be increased when it is combined with Amitriptyline.

Tocilizumab


The serum concentration of Amitriptyline can be decreased when it is combined with Tocilizumab.

Tolbutamide


The metabolism of Amitriptyline can be decreased when combined with Tolbutamide.

Tolcapone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tolcapone.

Toloxatone


Toloxatone may increase the serotonergic activities of Amitriptyline.

Topiramate


Topiramate may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.

Topotecan


The serum concentration of Topotecan can be increased when it is combined with Amitriptyline.

Toremifene


Amitriptyline may increase the QTc-prolonging activities of Toremifene.

Tramadol


Amitriptyline may increase the neuroexcitatory activities of Tramadol.

Trandolapril


The serum concentration of Amitriptyline can be increased when it is combined with Trandolapril.

Tranylcypromine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tranylcypromine.

Trazodone


The risk or severity of adverse effects can be increased when Trazodone is combined with Amitriptyline.

Triazolam


The risk or severity of adverse effects can be increased when Triazolam is combined with Amitriptyline.

Triazulenone


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Loprazolam.

Trifluoperazine


The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Amitriptyline.

Triflupromazine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Triflupromazine.

Trimethoprim


The metabolism of Amitriptyline can be decreased when combined with Trimethoprim.

Trimipramine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Trimipramine.

Triprolidine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Triprolidine.

Tropisetron


Tropisetron may increase the serotonergic activities of Amitriptyline.

Tryptophan


L-Tryptophan may increase the serotonergic activities of Amitriptyline.

Urethane


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethyl carbamate.

Valproate


The serum concentration of Amitriptyline can be increased when it is combined with Valproic Acid.

Valproic Acid


The serum concentration of Amitriptyline can be increased when it is combined with Valproic Acid.

Valsartan


The metabolism of Amitriptyline can be decreased when combined with Valsartan.

Vandetanib


Amitriptyline may increase the QTc-prolonging activities of Vandetanib.

Vemurafenib


The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Amitriptyline.

Venlafaxine


The risk or severity of adverse effects can be increased when Venlafaxine is combined with Amitriptyline.

Verapamil


The metabolism of Amitriptyline can be decreased when combined with Verapamil.

Vigabatrin


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Vigabatrin.

Vilanterol


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Vilanterol.

Vilazodone


The risk or severity of adverse effects can be increased when Vilazodone is combined with Amitriptyline.

Vildagliptin


The serum concentration of Amitriptyline can be increased when it is combined with Vildagliptin.

Vincristine


The excretion of Vincristine can be decreased when combined with Amitriptyline.

Voriconazole


The metabolism of Amitriptyline can be decreased when combined with Voriconazole.

Vortioxetine


The risk or severity of adverse effects can be increased when Vortioxetine is combined with Amitriptyline.

Warfarin


Amitriptyline may increase the anticoagulant activities of Warfarin.

Xylometazoline


Amitriptyline may decrease the antihypertensive activities of Xylometazoline.

Yohimbine


The serum concentration of Yohimbine can be increased when it is combined with Amitriptyline.

Zafirlukast


The metabolism of Amitriptyline can be decreased when combined with Zafirlukast.

Zaleplon


The risk or severity of adverse effects can be increased when Zaleplon is combined with Amitriptyline.

Ziconotide


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ziconotide.

Ziprasidone


Amitriptyline may increase the QTc-prolonging activities of Ziprasidone.

Zofenopril


The serum concentration of Amitriptyline can be increased when it is combined with Zofenopril.

Zolmitriptan


The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Amitriptyline.

Zolpidem


Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.

Zonisamide


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Zonisamide.

Zopiclone


The risk or severity of adverse effects can be increased when Zopiclone is combined with Amitriptyline.

Zotepine


The risk or severity of adverse effects can be increased when Amitriptyline is combined with Zotepine.

Zuclopenthixol


Amitriptyline may increase the QTc-prolonging activities of Zuclopenthixol.

Advertisement
Recommended Reading
Drugs A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
Mastering Diabetes: A Comprehensive Guide to Education and Self-Care – An Ebook
Stay Connected
Available on the Android Market Available on the App Store
Advertisement
Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education

Consumer

Professional